The Pathology Core will supply pathology support for the scientific community engaged in prostate research at ULLA. This will be accomplished through the following specific aims: Maintain an anonymous computerized database of well documented, annotated, and quality controlled tissues from donors after prostate surgery, including matched samples of normal and cancer tissue from prostatectomy specimens. Quality control includes histologic confirmation of all specimens by the pathologist. Formalin fixed tissue blocks will be available from archival files, as well as snap-frozen fresh tissues suitable for RNA and DNA extraction. Provide histology support including embedding of tissues, sectioning and staining. Perform immunohistochemistry an in-situ hybridization studies. Perform laser microdissection of prostate tissues. Provide tissue arrays from normal and carcinoma prostate tissues for high throughput evaluation of tumor markers by immunohistochemistry, FISH or other methods. Provide expertise with handling of tissues for experimental protocols, interpretation of prostate histology and special stains by an expert urologic pathologist. Provide support with animal tissues including all aspects of tissue processing, staining, and interpretation of histologic sections. Ensure that samples are collected according to IRB guidelines and that tissues and services are distribute fairly and in a timely manner to all investigators in the SPORE.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA092131-01A1
Application #
6689887
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-09-15
Project End
2007-06-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Mitra, Mithun; Lee, Ha Neul; Coller, Hilary A (2018) Determining Genome-wide Transcript Decay Rates in Proliferating and Quiescent Human Fibroblasts. J Vis Exp :
Zou, Yongkang; Qi, Zhi; Guo, Weilong et al. (2018) Cotargeting the Cell-Intrinsic and Microenvironment Pathways of Prostate Cancer by PI3K?/?/? Inhibitor BAY1082439. Mol Cancer Ther 17:2091-2099
Henning, Susanne M; Galet, Colette; Gollapudi, Kiran et al. (2018) Phase II prospective randomized trial of weight loss prior to radical prostatectomy. Prostate Cancer Prostatic Dis 21:212-220
Miller, Eric T; Salmasi, Amirali; Reiter, Robert E (2018) Anatomic and Molecular Imaging in Prostate Cancer. Cold Spring Harb Perspect Med 8:
Navarro, Héctor I; Goldstein, Andrew S (2018) HoxB13 mediates AR-V7 activity in prostate cancer. Proc Natl Acad Sci U S A 115:6528-6529
Mitra, Mithun; Ho, Linda D; Coller, Hilary A (2018) An In Vitro Model of Cellular Quiescence in Primary Human Dermal Fibroblasts. Methods Mol Biol 1686:27-47
Li, Jiayun; Speier, William; Ho, King Chung et al. (2018) An EM-based semi-supervised deep learning approach for semantic segmentation of histopathological images from radical prostatectomies. Comput Med Imaging Graph 69:125-133
Kang, Jung J; Reiter, Robert E; Kummer, Nicolas et al. (2018) Wrong to be Right: Margin Laterality is an Independent Predictor of Biochemical Failure After Radical Prostatectomy. Am J Clin Oncol 41:1-5
Lee, Ha Neul; Mitra, Mithun; Bosompra, Oye et al. (2018) RECK isoforms have opposing effects on cell migration. Mol Biol Cell 29:1825-1838
Aggarwal, Rahul; Huang, Jiaoti; Alumkal, Joshi J et al. (2018) Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study. J Clin Oncol 36:2492-2503

Showing the most recent 10 out of 339 publications